{"id":"t89-low-dose","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal upset"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"T89 (Danshen dripping pill) contains multiple active components that enhance ATP production in cardiac mitochondria, improve coronary blood flow, and reduce oxidative stress and apoptosis in ischemic myocardium. The formulation works through multiple pathways including mitochondrial protection, anti-inflammatory effects, and improvement of cardiac contractility.","oneSentence":"T89 is a traditional Chinese medicine compound that improves myocardial energy metabolism and reduces ischemic injury in cardiovascular disease.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:37:16.243Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Angina pectoris"},{"name":"Myocardial infarction"},{"name":"Heart failure"}]},"trialDetails":[{"nctId":"NCT04546230","phase":"NA","title":"Low-Thoracic Epidural Anesthesia For Laparoscopic Nephrectomy.","status":"RECRUITING","sponsor":"Nazmy Edward Seif","startDate":"2020-09-19","conditions":"Laparoscopic, Nephrectomy, Anesthesia","enrollment":80},{"nctId":"NCT03789552","phase":"PHASE3","title":"Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina","status":"RECRUITING","sponsor":"Tasly Pharmaceuticals, Inc.","startDate":"2019-08-01","conditions":"Chronic Stable Angina Pectoris","enrollment":765},{"nctId":"NCT04993729","phase":"PHASE3","title":"Safety and Efficacy of T89 in the Prevention and Treatment of Adults With Acute Mountain Sickness (AMS)","status":"COMPLETED","sponsor":"Tasly Pharmaceuticals, Inc.","startDate":"2021-07-21","conditions":"Acute Mountain Sickness (AMS)","enrollment":853},{"nctId":"NCT03552263","phase":"PHASE2","title":"Safety and Efficacy of T89 in Prevention and Treatment of Adults With Acute Mountain Sickness (AMS)","status":"COMPLETED","sponsor":"Tasly Pharmaceuticals, Inc.","startDate":"2018-06-07","conditions":"Acute Mountain Sickness (AMS)","enrollment":132},{"nctId":"NCT01659580","phase":"PHASE3","title":"Phase III Trial of Dantonic® (T89) Capsule to Prevent and Treat Stable Angina","status":"COMPLETED","sponsor":"Tasly Pharmaceuticals, Inc.","startDate":"2012-08","conditions":"Angina Pectoris","enrollment":1004},{"nctId":"NCT00797953","phase":"PHASE2","title":"Phase II Multi-Center Study of T89 to Treat Chronic Stable Angina","status":"COMPLETED","sponsor":"Tasly Pharmaceuticals, Inc.","startDate":"2007-02","conditions":"Angina Pectoris","enrollment":124}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Dantonic®","Salvtonic®","Compound Danshen Dripping Pill"],"phase":"phase_3","status":"active","brandName":"T89 Low dose","genericName":"T89 Low dose","companyName":"Tasly Pharmaceuticals, Inc.","companyId":"tasly-pharmaceuticals-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"T89 is a traditional Chinese medicine compound that improves myocardial energy metabolism and reduces ischemic injury in cardiovascular disease. Used for Angina pectoris, Myocardial infarction, Heart failure.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}